While cancers such as breast, lung, and prostate frequently dominate public health discussions, there is a far less recognised but equally aggressive form - sarcoma. It affects thousands across the UK ...
VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...
Oncology advancements focus on precision medicine, liquid biopsies, and novel therapies to improve outcomes and address care disparities. Value-based care models prioritize patient-centered approaches ...
Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial In 143 patients with rhabdomyosarcoma with ...
Every July, Sarcoma Awareness Month reminds us of a cancer that’s often sidelined in public discourse. However, sarcoma is not just one disease, it is a group of rare cancers with over 150 subtypes, ...
Iovance Biotherapeutics (IOVA) has become a focus for investors after new data for its Amtagvi therapy showed strong response and disease control rates in advanced melanoma and sarcoma, alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results